Drug profile · INN
iptacopan hydrochloride
FABHALTA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
iptacopan hydrochloride (FABHALTA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN iptacopan hydrochloride
Brand FABHALTA
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is iptacopan hydrochloride?
iptacopan hydrochloride (FABHALTA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for iptacopan hydrochloride?
FABHALTA is a marketed brand name for iptacopan hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of iptacopan hydrochloride?
iptacopan hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.